# Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19

> **NCT06218862** · — · COMPLETED · sponsor: **The First Hospital of Jilin University** · enrollment: 387 (actual)

## Conditions studied

- ARDS Due to Disease Caused by SARS Co-V-2

## Interventions

- **DRUG:** Sivelestat sodium
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT06218862
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06218862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06218862, "Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06218862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*